ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,460,884 | -83.4% | 70,100 | -80.9% | 0.00% | -81.8% |
Q2 2023 | $8,784,573 | +339.5% | 366,788 | +245.4% | 0.02% | +266.7% |
Q1 2023 | $1,998,684 | +1027.3% | 106,200 | +853.6% | 0.01% | +500.0% |
Q4 2022 | $177,301 | -78.6% | 11,137 | -81.1% | 0.00% | -66.7% |
Q2 2022 | $828,000 | -85.8% | 58,800 | -75.5% | 0.00% | -82.4% |
Q1 2022 | $5,824,000 | +856.3% | 240,471 | +821.3% | 0.02% | +1600.0% |
Q4 2021 | $609,000 | +133.3% | 26,100 | +66.2% | 0.00% | 0.0% |
Q3 2021 | $261,000 | -22.6% | 15,700 | +13.8% | 0.00% | 0.0% |
Q2 2021 | $337,000 | -97.6% | 13,800 | -95.2% | 0.00% | -98.6% |
Q2 2020 | $13,892,000 | +354.3% | 286,618 | +301.0% | 0.07% | +666.7% |
Q4 2019 | $3,058,000 | -59.4% | 71,480 | -65.9% | 0.01% | -64.0% |
Q3 2019 | $7,540,000 | +42.0% | 209,496 | +5.5% | 0.02% | +38.9% |
Q2 2019 | $5,309,000 | +24.9% | 198,623 | +34.8% | 0.02% | +12.5% |
Q4 2016 | $4,250,000 | – | 147,339 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |